366 related articles for article (PubMed ID: 31084277)
1. The Global State of Harm Reduction in Prisons.
Sander G; Shirley-Beavan S; Stone K
J Correct Health Care; 2019 Apr; 25(2):105-120. PubMed ID: 31084277
[TBL] [Abstract][Full Text] [Related]
2. The furthest left behind: the urgent need to scale up harm reduction in prisons.
Sander G; Murphy F
Int J Prison Health; 2017 Sep; 13(3-4):185-191. PubMed ID: 28914120
[TBL] [Abstract][Full Text] [Related]
3. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
Altice FL; Azbel L; Stone J; Brooks-Pollock E; Smyrnov P; Dvoriak S; Taxman FS; El-Bassel N; Martin NK; Booth R; Stöver H; Dolan K; Vickerman P
Lancet; 2016 Sep; 388(10050):1228-48. PubMed ID: 27427455
[TBL] [Abstract][Full Text] [Related]
4. Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth.
Stone KA
Harm Reduct J; 2015 Oct; 12():32. PubMed ID: 26472335
[TBL] [Abstract][Full Text] [Related]
5. Overview of harm reduction in prisons in seven European countries.
Sander G; Scandurra A; Kamenska A; MacNamara C; Kalpaki C; Bessa CF; Laso GN; Parisi G; Varley L; Wolny M; Moudatsou M; Pontes NH; Mannix-McNamara P; Libianchi S; Antypas T
Harm Reduct J; 2016 Oct; 13(1):28. PubMed ID: 27717368
[TBL] [Abstract][Full Text] [Related]
6. Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries.
Bielen R; Stumo SR; Halford R; Werling K; Reic T; Stöver H; Robaeys G; Lazarus JV
Harm Reduct J; 2018 May; 15(1):25. PubMed ID: 29751763
[TBL] [Abstract][Full Text] [Related]
7. Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users.
Chakrapani V; Kamei R; Kipgen H; Kh JK
Int J Prison Health; 2013; 9(2):82-91. PubMed ID: 25758440
[TBL] [Abstract][Full Text] [Related]
8. Within-prison drug injection among HIV-infected Ukrainian prisoners: prevalence and correlates of an extremely high-risk behaviour.
Izenberg JM; Bachireddy C; Wickersham JA; Soule M; Kiriazova T; Dvoriak S; Altice FL
Int J Drug Policy; 2014 Sep; 25(5):845-52. PubMed ID: 24951025
[TBL] [Abstract][Full Text] [Related]
9. Prisoners who inject drugs: public health and human rights imperatives.
Jürgens R; Betteridge G
Health Hum Rights; 2005; 8(2):46-74. PubMed ID: 17136903
[TBL] [Abstract][Full Text] [Related]
10. Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments.
Azbel L; Wegman MP; Polonsky M; Bachireddy C; Meyer J; Shumskaya N; Kurmanalieva A; Dvoryak S; Altice FL
Int J Prison Health; 2018 Sep; 14(3):175-187. PubMed ID: 30274558
[TBL] [Abstract][Full Text] [Related]
11. Access to hepatitis C care for people who inject drugs and people in prisons.
Oru E; Verster A
Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):662-663. PubMed ID: 31362917
[No Abstract] [Full Text] [Related]
12. The state of harm reduction in prisons in 30 European countries with a focus on people who inject drugs and infectious diseases.
Stöver H; Tarján A; Horváth G; Montanari L
Harm Reduct J; 2021 Jun; 18(1):67. PubMed ID: 34187471
[TBL] [Abstract][Full Text] [Related]
13. HIV prevalence and related risk behaviours among prisoners in Iran: results of the national biobehavioural survey, 2009.
Navadeh S; Mirzazadeh A; Gouya MM; Farnia M; Alasvand R; Haghdoost AA
Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii33-6. PubMed ID: 23986417
[TBL] [Abstract][Full Text] [Related]
14. Substitution treatment and HCV/HIV-infection in a sample of 31 German prisons for sentenced inmates.
Schulte B; Stöver H; Thane K; Schreiter C; Gansefort D; Reimer J
Int J Prison Health; 2009; 5(1):39-44. PubMed ID: 25758928
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study.
Bretaña NA; Gray RR; Cunningham EB; Betz-Stablein B; Ribeiro R; Graw F; Luciani F; Lloyd AR
Addiction; 2020 May; 115(5):901-913. PubMed ID: 31633853
[TBL] [Abstract][Full Text] [Related]
16. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
Dolan K; Wirtz AL; Moazen B; Ndeffo-Mbah M; Galvani A; Kinner SA; Courtney R; McKee M; Amon JJ; Maher L; Hellard M; Beyrer C; Altice FL
Lancet; 2016 Sep; 388(10049):1089-1102. PubMed ID: 27427453
[TBL] [Abstract][Full Text] [Related]
17. People who inject drugs in prison: HIV prevalence, transmission and prevention.
Dolan K; Moazen B; Noori A; Rahimzadeh S; Farzadfar F; Hariga F
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S12-5. PubMed ID: 25727258
[TBL] [Abstract][Full Text] [Related]
18. Harm Reduction Coverage and Hepatitis C Incidence: Findings From a Cohort of People Who Inject Drugs.
Minoyan N; Artenie AA; Zang G; Jutras-Aswad D; Turcotte MÈ; Bruneau J
Am J Prev Med; 2020 Jun; 58(6):845-853. PubMed ID: 32444003
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services.
Getahun H; Gunneberg C; Sculier D; Verster A; Raviglione M
Curr Opin HIV AIDS; 2012 Jul; 7(4):345-53. PubMed ID: 22678489
[TBL] [Abstract][Full Text] [Related]
20. Injecting substance use in prisons in the United States: a case for needle exchange programs.
Armstrong-Mensah E; Dada D; Rupasinghe R; Whately H
Am J Drug Alcohol Abuse; 2021 May; 47(3):273-279. PubMed ID: 33596124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
